EnWave Interview Provides Thorough Update on Current Status and Upcoming Milestones

2016 turns out to be an inflection point for EnWave Corp. (TSXV:ENW – $1.27 CAD & OTC:NWVCF – $0.94 USD). In the Company’s second quarter, which ended March 31st, it reported a positive net income for the first time in its history. And in the third quarter, revenues and earnings were even higher. So it was high time to speak with Mr. Brent Charleton, the Senior Vice President Business Development at EnWave, to find out what more is in the pipeline.

When talking about the Company’s financial results, Mr. Charleton confirms that he foresees several strong quarters ahead. He also shares his thoughts on the royalties that EnWave receives on commercial products that were produced with REV machinery.

Mr. Charleton delivers plenty of valuable information about the several segments of the dried products market in which EnWave is significantly growing. He discusses the current status and opportunities in each one.

He gives his outlook for Moon Cheese, the popular cheese snack that’s being produced at EnWave’s 51% owned subsidiary NutraDried. In addition, the Senior Vice President provides a thorough overview of the progress, which the commercial partners, that are active in the dairy sector, have already made.

The interview also digs deeper into EnWave’s relationship with Bonduelle and the developments that are ahead with this worldwide leading processed vegetable producer.

A final sector on which Mr. Charleton provides critical information is pharmaceuticals. He talks about the progress with Sutro Biopharma and Merck, and the upcoming milestones with both companies.

Moreover, the interview touches upon Dr. Tom Yang, a food technologist at the U.S. Army Combat Feeding Directorate, and the potential application of REV technology in the U.S. Army.

For important disclosures, please read our disclaimer.

Latest Company Report (pdf)